117 results on '"Minushkina, L. O."'
Search Results
2. Prospects for Using Chromatography-Mass Spectrometry for the Determination of Lipids in Clinical Cardiolipidology
3. Which scale is best to assess the risk of upper gastrointestinal bleeding in patients with stable coronary artery disease in the Russian population?
4. Incidence of familial hypercholesterolemia in patients with early manifestations of coronary artery disease: data from a Russian multicenter study and meta-analysis
5. A NEW DIRECTION OF OPPORTUNIST SCREENING FOR FAMILY HYPERCHOLESTEROLEMIA IN THE PRIMARY HEALTH CARE SYSTEM IN MOSCOW
6. Premature atherosclerotic cardiovascular disease: association of clinical factors with form of atherosclerosis onset
7. Polymorphic markers Ala455Val of the THBD gene and Arg353Gln of the F7 gene and genetic association with unfavorable outcomes of coronary atherosclerosis in patients with a history of acute ischemic heart disease
8. The polymorphisms G(−174)C in IL6 gene and G(−1082)A in IL10 gene are associated with poor outcomes in patients with acute coronary syndrome
9. Association of the polymorphic markers G(−455)A in the FGB gene and C(−1654)T in the PROC gene with hereditary predisposition to unfavourable outcome in patients with history of acute coronary syndrome
10. Left ventricular global function index as a predictor of adverse cardiovascular events in patients with acute coronary syndrome
11. Association of GNB3 gene C825T polymorphism with coronary heart disease
12. Visit-to-visit blood pressure variability in patients after acute coronary syndrome
13. Association of Polymorphic Marker G(−455)A of Gene FGB with Coronary Artery Disease
14. Association of the T174M and M235T Polymorphisms of the Angiotensinogen Gene with Coronary Heart Disease in Ethnic Russians from Moscow
15. Polymorphic Markers at the Genes Encoding the Endothelial NO-Synthase and Angiotensin II Type 1 Receptor and the Susceptibility to Ischemic Heart Disease
16. Using the ORACLE Risk Score to Assess Hemorrhagic Risk in Patients with Acute Coronary Syndrome and Atrial Fibrillation
17. Bleeding risk scales in patients with acute coronary syndrome: place of the ORACUL scale
18. Changes in the management of patients with acute coronary syndrome – have the disease outcomes changed?
19. The Risk of Developing Ischemic Stroke in Patients After Exacerbation of Ischemic Heart Disease
20. AGE-RELATED DIFFERENCES IN THE DISEASE COURSE AND RISK FACTORS FOR UNFAVORABLE OUTCOMES IN PATIENTS WITH ACUTE CORONARY SYNDROME
21. Association of Polymorphic Marker A1/A2 of Gene ITGB3 with Coronary Artery Disease and Myocardial Infarction
22. Association of the G7831A Polymorphism of the ACE Gene with Coronary Heart Disease in Muscovites
23. SCREENING OF FAMILIAL HYPERLIPIDEMIA IN REAL AMBULATORY PRACTICE
24. External validation of the ORACLE bleeding risk score using the database of the RECORD 3 registry
25. MODERN ADVANCED ARTIFICIAL INTELLIGENCE FOR SMART MEDICINE
26. Bleeding risk factors in patients with acute coronary syndrome: data from observational studies ORACUL II
27. PRIMARY PREVENTION OF CARDIOVASCULAR DISEASE AND ANTIPLATELET THERAPY. CLINICAL LECTURE
28. THE CLINICAL CASE OF DETECTION OF TICKS GENUS DEMODEX OF ATYPICAL LOCALIZATION
29. THE STUDY OF ARTERIAL RIGIDITY IN OUT-PATIENT PRACTICE AMONG INDIVIDUALS OF ABLE-BODIED AGE
30. THE RISK FACTORS OF DEVELOPMENT AND PROGRESSION OF CALCINED AORTIC STENOSIS
31. The possibilities of medicinal therapy in patients with calcined aortic stenosis
32. GENETIC POLYMORPHISM OF THE INFLAMMATORY CYTOKINE GENES AND ARTERIAL WALL PROPERTIES IN HYPERTENSIVE PATIENTS
33. EXPERIENCE IN THE USE OF ORAL ANTICOAGULANTS IN OUTPATIENT CLINICS
34. LEFT VENTRICULAR HYPERTROPHY DEVELOPMENT, ASSOCIATED WITH GENETIC POLYMORPHISM OF INFLAMMATORY MEDIATORS
35. Treatment of patient with high-risk hypertension: do we need antiplatelet therapy?
36. Candesartan in treating hypertension
37. COMBINATION THERAPY IN THE MANAGEMENT OF ARTERIAL HYPERTENSION: EFFECTIVENESS OF THE LERCANIDIPINE AND ENALAPRIL COMBINATION
38. Hypertension treatment: Is there a place for b-adrenoblockers?
39. Association of Polymorphic Marker G(–455)A of Gene FGB with Coronary Artery Disease.
40. Genetic aspects of individual sensitivity to betaxolol in patients with arterial hypertension
41. Individual sensitivity to antihypertensive drugs: Genetic aspects
42. Prognostic Value of Aortic Stenosis in Patients After Acute Coronary Sindrom
43. Functional state of endothelium in patients with hypertension and ischemic heart disease
44. Endothelium Dysfunction: Relation to Angiotensin Receptor Gene Polymorphism in Patients with Ischemic Heart Disease
45. Genetic aspects of development of microalbuminuria in patients with hypertensive disease
46. [Polymorphic markers G(-455)A of gene FGB and C(-1654)T of gene PROC and genetic predisposition to unfavorable outcomes patients undergoing acute coronary syndrome]
47. Association of GNB3 gene C825T polymorphism with coronary heart disease
48. Myocardial hypertrophy in patients with hypertensive disease: The role of genetic polymorphism of β-adrenoreactive structures
49. Association of genetic factors with clinical peculiarities of hypertensive disease in patients with burdened familial anamnesis
50. The role of genetic factors in development of atrial fibrillation
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.